Stock-Based Compensation and Shareholders’ Equity (Tables)

12 Months Ended

Nov. 01, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Share-Based Payment Arrangement, Expensed Amount

Total stock-based compensation expense recognized is as follows:

	2025		2024		2023
Cost of sales	$	40,202	$	31,233	$	36,703
Research and development	134,245		109,011		116,354
Selling, marketing, general and administrative	142,286		114,638		143,789
Special charges, net	4,827		7,828		2,977
Total stock-based compensation expense	$	321,560	$	262,710	$	299,823

Schedule of The Activity Under the Company's Stock Option Plans

A summary of the stock option activity as of November 1, 2025 and changes during the fiscal year then ended is presented below:

	Options Outstanding (in thousands)	Weighted- Average Exercise Price Per Share	Weighted- Average Remaining Contractual Term in Years	Aggregate Intrinsic Value
Options outstanding at November 2, 2024	1,639	$105.94
Options exercised	(441)	$81.09
Options forfeited	(1)	$68.77
Options outstanding and exercisable at November 1, 2025	1,197	$115.14	3.7	$142,441

Schedule of The Company's Restricted Stock Unit Award Activity

A summary of the Company’s restricted stock unit and award activity as of November 1, 2025 and changes during the fiscal year then ended is presented below:

	Restricted Stock Units/Awards Outstanding (in thousands)	Weighted- Average Grant- Date Fair Value Per Share
Restricted stock units/awards outstanding at November 2, 2024	4,481	$186.81
Units/Awards granted	2,379	$164.33
Restrictions lapsed	(1,957)	$172.32
Forfeited	(476)	$191.82
Restricted stock units/awards outstanding at November 1, 2025	4,427	$180.59